Results 91 to 100 of about 7,987 (192)
The efficacy and safety of apatinib in Ewing’s sarcoma: a retrospective analysis in one institution
, 2018 Yitian Wang,* Li Min,* Yong Zhou, Yi Luo, Hong Duan, Chongqi Tu Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, People’s Republic of China *These authors contributed equally to this work Background ...
Min L +5 more
core
Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma [PDF]
Jiaran Zhang,1,* Huichun Tian,1,* Lili Mao,1 Caili Li,1 Xiaoting Wei,1 Junjie Gu,1 Xuan Wang,1 Li Zhou,2 Bin Lian,1 Bixia Tang,1 Xieqiao Yan,2 Siming Li,2 Chuanliang Cui,1 Zhihong Chi,1 Xinan Sheng,2 Jun Guo,1 Lu Si1 1Department of ...
Zhou L +16 more
core
, 2022 BackgroundAs a potent inhibitor of the vascular endothelial growth factor (VEGF) signaling pathway, Apatinib has been used in antitumor treatment for some time. The study aimed to research the therapeutic effects and toxicity of Apatinib in the treatment
Yibin Jia (3581321) +6 more
core +1 more source
BMC Cancer, 2018 Background Hepatocellular carcinoma (HCC) is a common cancer worldwide, with a poor prognosis. Most patients are diagnosed at advanced stages and are only eligible for palliative therapy. Therefore, this study aimed to evaluate the safety and efficacy of
Shiguang Chen +3 more
doaj +1 more source
Effective apatinib treatment of pleomorphic liposarcoma
Medicine, 2017 Pleomorphic liposarcoma (PLS) is a rare and aggressive malignant tumor, and both radiation and conventional cytotoxic chemotherapy remain controversial for metastatic or unresectable disease.We presented an 81-year-old Chinese woman with advanced PLS who received apatinib after failure chemotherapy.The patient was diagnosed as having PLS by biopsy ...
Yan, Peng +3 more
openaire +2 more sources
Apatinib in metastatic gastric cancer: can paclitaxel make the difference?
, 2016 Apatinib in metastatic gastric cancer: can paclitaxel make the difference?
ROVIELLO, FRANCO +4 more
core +1 more source
Cancer Management and Research, 2021 Jiaqiang Wang,1 Shilei Gao,1 Yonghao Yang,2 Xu Liu,1 Peng Zhang,1 Shuping Dong,1 Xin Wang,1 Weitao Yao1 1Department of Orthopedics, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan Province, 450008 ...
Wang J +7 more
doaj
A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy [PDF]
Fengyi Yang,1,2,* Qiaoyan Dong,3,* Zhuo Chen,1,2,* Benjian Gao,1,2,* Dongning Zheng,1,2 Rui Wang,1,2 Shu Qin,1,2 Fangyi Peng,1,2 Ming Luo,1,2 Jin Yang,1,2 Mengmei Nie,4 Bo Li,1,2 Xiaoli Yang1,2 1Department of General Surgery ...
Gao B +12 more
core
, 2018 Background Desmoplastic small round cell tumor (DSRCT) is a rare malignant sarcoma with poor prognosis due to lack of effective treatments. Apatinib is a new potent oral small-molecule tyrosine kinase inhibitor, and targets the intracellular domain of ...
Ye Feng +5 more
core +1 more source
Cancer management and research, 2019 Despite recent advances in the treatment of advanced ovarian cancer, drug selection after second-line chemotherapy has not been well studied. In this study, we retrospectively evaluated the effect and safety of apatinib as monotherapy or in combination with chemotherapy for the treatment of advanced ovarian cancer after second-line treatment.We ...
Yang,Mi +7 more
openaire +4 more sources